You won’t be seeing Yaz birth control ads on TV anymore — or at least not the ones that the pharmaceutical company Bayer has been using. On October 3, the FDA issued a warning letter to the company, telling Bayer its ads overstate the benefits of Yaz. While the drug is approved for symptoms related to treatment of premenstrual dysphoric disorder, or PMDD, it is not approved for the treatment of the less serious premenstrual syndrome, or PMS. Similarly, Yaz is approved for the treatment of moderate acne, but the FDA said the ad suggests it is approved for acne of all severities. Just another reason not believe everything you hear on TV. [Medical News Today]
Keep reading »
Simply Irresistible
Frisky Chatter
frisky chatter
Facebook Like
Like us on facebook




